Merrimack Pharmaceuticals is an integrated, biopharmaceutical company committed to the innovation of life-enhancing medicines for the treatment of autoimmune disease and cancer. Merrimack is privately held and located in Cambridge, Massachusetts.

 

LATEST NEWS

June 25, 2009 - Media Alert
'Science Signaling' to Publish Paper on Therapeutically Targeting ErbB3 to Treat Overexpressed or Mutated Oncognes.

April 18 - 22, 2009
Merrimack Pharmaceuticals to Present Multiple Poster Sessions at the American Association of Cancer Research 100th Annual Meeting in Denver, CO.

April 16, 2009 - Media Alert
Merrimack Pharmaceuticals to Present Pre-clinical Data on MM-121 and MM-111 at the Annual Meeting of the American Association of Cancer Research.

 
       
   
About Pipeline Research & Development News & Events Careers Contact Merrimack Pharmaceuticals